Pages

Tuesday, September 7, 2021

Revlimid drug: Biocon enters patent litigation settlement with Celgene

Revlimid drug: Biocon enters patent litigation settlement with Celgene Celgene Corporation earlier filed a complaint against Biocon over potential patent infringement by a potential generic drug created by Biocon.

from Moneycontrol Business News https://ift.tt/3zSDVsU

No comments:

Post a Comment